Insider Trading25 Jun 2026, 08:00 pm
Sun Pharma Closes Trading Window for Q2 FY27 Results
AI Summary
Sun Pharmaceutical Industries Ltd has announced the closure of its trading window for dealing in the company's shares. This closure will be effective from July 1, 2026, and will remain in effect until 48 hours after the declaration of the Unaudited Financial Results for the quarter ended June 30, 2026. The specific date for the Board Meeting to approve these results will be communicated later. This measure is in accordance with the company's Code of Conduct for Prohibition of Insider Trading, aimed at preventing potential misuse of unpublished price-sensitive information.
Key Highlights
- Trading window closure effective July 1, 2026.
- Closure is for the period leading up to Q2 FY27 financial results.
- Aims to prevent insider trading.
- Company will announce the board meeting date for results soon.
Price Impact
More from SUNPHARMA